{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:31:47Z","timestamp":1792409507052,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute kidney disease (AKD) evolves a spectrum of acute and subacute kidney disease requiring a global strategy to address. The present study aimed to explore the impact of AKD on the prognosis of ischemic stroke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Third China National Stroke Registry (CNSR-III) was a nationwide registry of ischemic stroke or transient ischemic attack between August 2015 and March 2018. As a subgroup of CNSR-III, the patients who had serum creatinine (sCr) and serum cystatin C (sCysC) centrally tested on admission and at 3-month, and with 1-year follow-up data were enrolled. Modified AKD criteria were applied to identify patients with AKD during the first 3\u00a0months post stroke according to the guidelines developed by the Kidney Disease: Improving Global Outcomes in 2012. The primary clinical outcome was 1-year all-cause death, and secondary outcomes were stroke recurrence and post stroke disability.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Five thousand sixty-five patients were recruited in the study. AKD was identified in 3.9%, 6.7%, 9.9% and 6.2% of the patients by using sCr, sCr-based estimated glomerular filtration rate (eGFR<jats:sub>sCr<\/jats:sub>), sCysC-based eGFR (eGFR<jats:sub>sCysC<\/jats:sub>), and combined sCr and sCysC-based eGFR (eGFR<jats:sub>sCr+sCysC<\/jats:sub>) criteria, respectively. AKD defined as sCr or eGFR<jats:sub>sCr<\/jats:sub> criteria significantly increased the risk of all-cause mortality (adjusted HR 2.67, 95% CI: 1.27\u20135.61; adjusted HR 2.19, 95% CI: 1.17\u20134.10) and post stroke disability (adjusted OR 1.60, 95% CI: 1.04\u20132.44; adjusted OR 1.51, 95% CI: 1.08\u20132.11). AKD diagnosed by eGFR<jats:sub>sCysC<\/jats:sub> or eGFR<jats:sub>sCr+sCysC<\/jats:sub> criteria had no significant impact on the risk of all-cause death and post stroke disability. AKD, defined by whichever criteria, was not associated with the risk of stroke recurrence in the adjusted model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>AKD, diagnosed by sCr or eGFR<jats:sub>sCr<\/jats:sub> criteria, were independently associated with 1-year all-cause death and post stroke disability in Chinese ischemic stroke patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02817-4","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T07:03:50Z","timestamp":1652857430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of acute kidney disease with the prognosis of ischemic stroke in the Third China National Stroke Registry"],"prefix":"10.1186","volume":"23","author":[{"given":"Yilun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuesong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"2817_CR1","unstructured":"National Kidney Foundation: Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1\u2013138."},{"key":"2817_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2215\/CJN.06150613","volume":"9","author":"R Chu","year":"2014","unstructured":"Chu R, Li C, Wang S, Zou W, Liu G, Yang L. Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. Clin J Am Soc Nephrol. 2014;9:1175\u201382.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2817_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/STROKEAHA.108.520882","volume":"40","author":"G Yahalom","year":"2009","unstructured":"Yahalom G, Schwartz R, Schwammenthal Y, Merzeliak O, Toashi M, Orion D, et al. Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke. 2009;40:1296\u2013303.","journal-title":"Stroke"},{"key":"2817_CR4","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.jtcvs.2018.01.093","volume":"155","author":"KA Mizuguchi","year":"2018","unstructured":"Mizuguchi KA, Huang CC, Shempp I, Wang J, Shekar P, Frendl G. Predicting kidney disease progression in patients with acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg. 2018;155:2455\u201363.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2817_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.2215\/CJN.04110808","volume":"4","author":"G Tsagalis","year":"2009","unstructured":"Tsagalis G, Akrivos T, Alevizaki M, Manios E, Theodorakis M, Laggouranis A, et al. Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol. 2009;4:616\u201322.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2817_CR6","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/ndt\/gfn471","volume":"24","author":"G Tsagalis","year":"2009","unstructured":"Tsagalis G, Akrivos T, Alevizaki M, Manios E, Stamatellopoulos K, Laggouranis A, et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant. 2009;24:194\u2013200.","journal-title":"Nephrol Dial Transplant"},{"key":"2817_CR7","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/ndt\/gfm591","volume":"23","author":"A Covic","year":"2008","unstructured":"Covic A, Schiller A, Mardare NG, Petrica L, Petrica M, Mihaescu A, et al. The impact of acute kidney injury on short-term survival in an Eastern European population with stroke. Nephrol Dial Transplant. 2008;23:2228\u201334.","journal-title":"Nephrol Dial Transplant"},{"key":"2817_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/svn-2019-000242","volume":"4","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jing J, Meng X, Pan Y, Wang Y, Zhao X, et al. The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics. Stroke Vasc Neurol. 2019;4:158\u201364.","journal-title":"Stroke Vasc Neurol"},{"key":"2817_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35\u201341.","journal-title":"Stroke."},{"key":"2817_CR10","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0140-6736(16)30240-9","volume":"387","author":"RL Mehta","year":"2016","unstructured":"Mehta RL, Burdmann EA, Cerd\u00e1 J, Feehally J, Finkelstein F, Garc\u00eda-Garc\u00eda G, et al. Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional study. Lancet. 2016;387:2017\u201325.","journal-title":"Lancet"},{"key":"2817_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0140-6736(15)00344-X","volume":"386","author":"L Yang","year":"2015","unstructured":"Yang L, Xing G, Wang L, Wu Y, Li S, Xu G, et al. Acute kidney injury in China: a cross-sectional survey. Lancet. 2015;386:1465\u201371.","journal-title":"Lancet"},{"key":"2817_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20\u20139.","journal-title":"N Engl J Med"},{"key":"2817_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1214234","volume":"369","author":"MG Shlipak","year":"2013","unstructured":"Shlipak MG, Matsushita K, \u00c4rnl\u00f6v J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369:932\u201343.","journal-title":"N Engl J Med"},{"key":"2817_CR14","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1161\/01.ATV.0000168416.74206.62","volume":"25","author":"M Loew","year":"2005","unstructured":"Loew M, Hoffmann MM, Koenig W, Brenner H, Rothenbacher D. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events. Arterioscler Thromb Vasc Biol. 2005;25:1470\u20134.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2817_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s12031-019-01373-1","volume":"69","author":"Y Wang","year":"2019","unstructured":"Wang Y, Li W, Yang J, Zhang M, Tian C, Ma M, et al. Association between Cystatin C and the risk of ischemic stroke: a systematic review and meta-analysis. J Mol Neurosci. 2019;69:444\u20139.","journal-title":"J Mol Neurosci"},{"key":"2817_CR16","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.2353\/ajpath.2010.100829","volume":"177","author":"L D'Adamio","year":"2010","unstructured":"D\u2019Adamio L. Role of cystatin C in neuroprotection and its therapeutic implications. Am J Pathol. 2010;177:2163\u20135.","journal-title":"Am J Pathol"},{"key":"2817_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/STROKEAHA.116.014975","volume":"48","author":"Z Fang","year":"2017","unstructured":"Fang Z, Deng J, Wu Z, Dong B, Wang S, Chen X, et al. Cystatin C is a crucial endogenous protective determinant against stroke. Stroke. 2017;48:436\u201344.","journal-title":"Stroke"},{"key":"2817_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13:241\u201357.","journal-title":"Nat Rev Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02817-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T07:05:47Z","timestamp":1652857547000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02817-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2817"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02817-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CNSR-III study was performed in accordance with the Declaration of Helsinki, and was approved by ethics committee at Beijing Tiantan Hospital (IRB approval number: KY2015-001\u201301) and all participating centres []. Written informed consent was got from patient or legally authorized representative (primarily spouse, parents, adult children, otherwise indicated).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests relevant to the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}